Notification of the mdr was provided through a letter from the fda dated on (b)(4) 2014.The letter was received at ivera on (b)(4) 2014.The reported device was not returned by the user facility nor was the lot number communicated.Without the device or lot number, ivera is not able to investigated the reported issue.Contact was made with the user facility, which they indicated that issues were minor and non-significant.There was no patient of safety related incident and they have not had any additional issues since the recent reports.Ivera did review verification requirements that are conducted in manufacturing of the product.Sampling is conducted on a continuous periodic basis, which tensile verification is part of inspection to confirm that a minimum retention force when engaged with a needleless luer activated valve (lav).Manufacturing limits are established on the manufacturing equipment, which is monitored real-time.If an excursion occurs outside the manufacturing limits, the manufacturing equipment will automatically segregate product produced at the time the excursion occurs.
|